UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Diagnosis and Treatment of Chronic Myelomonocytic Leukemias in Adults

HemaSphere, 2018-12, Vol.2 (6), p.n/a

2018

Volltextzugriff (PDF)

Hematopoietic stem cells exhibit a specific ABC transporter gene expression profile clearly distinct from other stem cells

BMC pharmacology, 2010-09, Vol.10 (1), p.12-12, Article 12

2010

Volltextzugriff (PDF)

Validation of the Qualms Questionnaire to Assess Health-Related Quality of Life in European and Israeli Patients with Myelodysplastic Syndromes: Results from the MDS-Right Project

Blood, 2021-11, Vol.138 (Supplement 1), p.1982-1982

2021

Volltextzugriff (PDF)

Management of MDS with Isolated Del(5q) Patients in the European MDS (EUMDS) Registry: A Report on 197 Cases

BLOOD, 2022-11, Vol.140 (Supplement 1), p.9802-9803

2022

Volltextzugriff (PDF)

Somatic Mutations and DNA Hypermethylation at Enhancers and Promoters Identify Distinct Subtypes within Lower-Risk Myelodysplastic Syndromes

Blood, 2023, Vol.142 (Supplement 1), p.4587-4587

2023

Volltextzugriff (PDF)

Management of MDS with Isolated Del(5q) Patients in the European MDS (EUMDS) Registry, a Unique Prospective Real-World Dataset

BLOOD, 2021-11, Vol.138 (Supplement 1), p.4671-4671

2021

Volltextzugriff (PDF)

Presentation name: What we learn from real-world registries

Leukemia research, 2021-09, Vol.108, p.106682, Article 106682.11

de Witte, Prof. Dr. Theo

2021

Volltextzugriff (PDF)

S11 - Presentation name: What we learn from real-world registries: LESSONS FROM THE LONGTERM EXPERIENCE OF THE EUROPEAN MDS REGISTRY

Leukemia research, 2021-09, Vol.108

de Witte, Prof. Dr. Theo

2021

Volltextzugriff (PDF)

Allogeneic Stem Cell Transplantation for Myelodysplastic Syndromes: Critical for Cure?

Clinical lymphoma, myeloma and leukemia, 2011-06, Vol.11, p.S46-S48

de Witte, Theo

2011

Volltextzugriff (PDF)

Deriving Core Patient-Reported Outcomes in Patients with Myelodysplastic Syndromes — a Delphi Survey from the European-MDS Registry

Blood, 2018-11, Vol.132 (Supplement 1), p.2295-2295

2018

Volltextzugriff (PDF)

Allogenic stem cell transplantation in the Netherlands

Nederlands tijdschrift voor geneeskunde, 2009-02, Vol.153 (9), p.380

2009

Volltextzugriff (PDF)

Longitudinal Changes of Impairments in Health-Related Quality of Life in Lower-Risk MDS Patients: A European Leukemianet Study

Blood, 2018-11, Vol.132 (Supplement 1), p.3097-3097

2018

Volltextzugriff (PDF)

Excess Mortality in Low-Risk MDS Can be Explained By MDS and AML Related Causes of Death

BLOOD, 2018-11, Vol.132 (Supplement 1), p.4385-4385

2018

Volltextzugriff (PDF)

Ratify (Alliance 10603): Prognostic Impact of FLT3 tyrosine Kinase Domain (TKD) and NPM1 Mutation Status in Patients with Newly Diagnosed Acute Myeloid Leukemia (AML) Treated with Midostaurin or Placebo Plus Standard Chemotherapy

Blood, 2018-11, Vol.132 (Supplement 1), p.2668-2668

2018

Volltextzugriff (PDF)

MDS Diagnosis: Many Patients May Not Require Bone Marrow Examination

BLOOD, 2018-11, Vol.132 (Supplement 1), p.4357-4357

2018

Volltextzugriff (PDF)

Unrelated stem cell transplantation after reduced intensity conditioning for patients with multiple myeloma relapsing after autologous transplantation: A prospective multicenter phase II study of the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT)

British journal of haematology, 2010, Vol.148 (2), p.323-331

2010

Volltextzugriff (PDF)

1 – 25 von 169

Suche als RSS-Feed

Aktive Filter

ThemaScience & Technology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(154)
Mit Volltextzugriff
(157)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

High-dose therapy and autologous stem cell transplantation in patients with POEMS syndrome: a retrospective study of the Plasma Cell Disorder sub-committee of the Chronic Malignancy Working Party of the European Society for Blood & Marrow Transplantation

P731: SURVIVAL IN LOWER‐RISK MDS PATIENTS FROM EUMDS REGISTRY BY TWO TRANSPLANT SELECTION CRITERIA ‐ IMPLICATIONS FOR TRANSPLANT DECISION

Low-dose clofarabine in combination with a standard remission induction in patients aged 18-60 years with previously untreated intermediate and bad-risk acute myeloid leukemia or high-risk myelodysplastic syndrome: combined phase I/II results of the EORTC/GIMEMA AML-14A trial

Diagnosis and Treatment of Chronic Myelomonocytic Leukemias in Adults

Hematopoietic stem cells exhibit a specific ABC transporter gene expression profile clearly distinct from other stem cells

Validation of the Qualms Questionnaire to Assess Health-Related Quality of Life in European and Israeli Patients with Myelodysplastic Syndromes: Results from the MDS-Right Project

Management of MDS with Isolated Del(5q) Patients in the European MDS (EUMDS) Registry: A Report on 197 Cases

Somatic Mutations and DNA Hypermethylation at Enhancers and Promoters Identify Distinct Subtypes within Lower-Risk Myelodysplastic Syndromes

Management of MDS with Isolated Del(5q) Patients in the European MDS (EUMDS) Registry, a Unique Prospective Real-World Dataset

Retrospective comparison of reduced-intensity conditioning and conventional high-dose conditioning for allogeneic hematopoietic stem cell transplantation using HLA-identical sibling donors in myelodysplastic syndromes

Presentation name: What we learn from real-world registries

S11 - Presentation name: What we learn from real-world registries: LESSONS FROM THE LONGTERM EXPERIENCE OF THE EUROPEAN MDS REGISTRY

Consensus proposal for revised International Working Group response criteria for higher risk myelodysplastic syndromes

Mutation Profiles Identify Distinct Clusters of Lower Risk Myelodysplastic Syndromes with Unique Clinical and Biological Features and Clinical Endpoints

Allogeneic Stem Cell Transplantation for Myelodysplastic Syndromes: Critical for Cure?

Deriving Core Patient-Reported Outcomes in Patients with Myelodysplastic Syndromes — a Delphi Survey from the European-MDS Registry

I-Care for MDS: Development of Guidelines-Based Indicators for Appropriate Care in Adult Patients with Myelodysplastic Syndromes

Allogenic stem cell transplantation in the Netherlands

Longitudinal Changes of Impairments in Health-Related Quality of Life in Lower-Risk MDS Patients: A European Leukemianet Study

Excess Mortality in Low-Risk MDS Can be Explained By MDS and AML Related Causes of Death

Elevated Labile Plasma Iron (LPI) Levels in Patients with Lower-Risk Myelodysplastic Syndromes (MDS) Are Associated with Decreased Quality of Life and Reduced Survival

Prognostic Impact of Insertion Site in Acute Myeloid Leukemia (AML) with FLT3 Internal Tandem Duplication: Results from the Ratify Study (Alliance 10603)

Ratify (Alliance 10603): Prognostic Impact of FLT3 tyrosine Kinase Domain (TKD) and NPM1 Mutation Status in Patients with Newly Diagnosed Acute Myeloid Leukemia (AML) Treated with Midostaurin or Placebo Plus Standard Chemotherapy

MDS Diagnosis: Many Patients May Not Require Bone Marrow Examination

Unrelated stem cell transplantation after reduced intensity conditioning for patients with multiple myeloma relapsing after autologous transplantation: A prospective multicenter phase II study of the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT)

Aktive Filter

Suchergebnisse filtern